Overview

Synthetic Human Secretin in Children With Autism

Status:
Completed
Trial end date:
2004-01-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine whether multiple doses of secretin are safe and effective in the treatment of children with autism.
Phase:
Phase 3
Details
Lead Sponsor:
Repligen Corporation
Treatments:
Secretin